Your session is about to expire
← Back to Search
Behavioral Intervention
AAC Technology for Child Hearing Loss
N/A
Recruiting
Led By Jareen Meinzen-Derr, PhD
Research Sponsored by Children's Hospital Medical Center, Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Currently receiving speech-language therapy
Documented permanent bilateral hearing loss with severity levels clinically defined in any range (mild to profound)
Must not have
Children with severe communication disorders (i.e. autism spectrum disorders)
Significant motor impairments
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change between baseline and 24 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether AAC technology can help improve language development in deaf or hard of hearing children.
Who is the study for?
This trial is for children with a language gap and documented permanent bilateral hearing loss of any severity who are already receiving speech-language therapy. It excludes those whose primary language isn't English, have significant motor impairments, nonverbal IQ below 60, or severe communication disorders like autism.
What is being tested?
The study tests if using augmentative and alternative communication (AAC) technology can improve language development in deaf or hard-of-hearing children. Participants will either receive AAC tech alongside their usual speech therapy or continue with their current care without the tech.
What are the potential side effects?
Since this trial involves educational technology rather than medication, traditional side effects aren't expected. However, there may be indirect effects on behavior or frustration levels due to adapting to new technologies.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am currently undergoing speech-language therapy.
Select...
I have permanent hearing loss in both ears.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
My child has a severe communication disorder like autism.
Select...
I have major difficulties with movement.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change between baseline and 24 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change between baseline and 24 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Discourse
Syntax
semantics
Secondary study objectives
Language standard scores (receptive and expressive)
Social functioning
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Technology-assisted language interventionExperimental Treatment1 Intervention
This intervention will incorporate augmentative and alternative communication software delivered on iPads into speech-language therapy
Group II: usual careActive Control1 Intervention
This group will be usual care children are already receiving.
Find a Location
Who is running the clinical trial?
Children's Hospital Medical Center, CincinnatiLead Sponsor
839 Previous Clinical Trials
6,565,449 Total Patients Enrolled
3 Trials studying Hearing Loss
169 Patients Enrolled for Hearing Loss
Children's Hospital ColoradoOTHER
120 Previous Clinical Trials
5,133,037 Total Patients Enrolled
Jareen Meinzen-Derr, PhDPrincipal InvestigatorChildren's Hospital Medical Center, Cincinnati
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My child has a severe communication disorder like autism.I am currently undergoing speech-language therapy.I have major difficulties with movement.I have permanent hearing loss in both ears.Your nonverbal IQ score is less than 60.